French version of the Schizophrenia Proneness Instrument for children and adolescents (SPI-CY)

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter work enrolls French-speaking adolescents aged 12 to 17 who are already identified as being at clinical high risk for psychosis and administers the SPI-CY interview, with audio recording of sessions. Investigators will examine the instrument's reliability and how well its scores agree with existing clinical measures such as CAARMS and clinical judgment. The goal is to produce psychometric data (e.g., internal consistency, interrater reliability, and predictive indicators) for the French version. The project is conducted at three French centers (Nancy, Lille, Saint-Egrève) using standard psychiatric diagnostic interview procedures.

Why it matters

Who can join: the full rules

Inclusion Criteria :

* Patients (men or women) followed at one of the 3 following structures in France : CLIP-Ado Nancy, CH Alpes-Isère, CHRU Lille for a suspected mental state at risk of developing psychosis, as determined by the CAARMS scale and/or the SPI-CY scale.
* Age between 12 and 17 years and 11 months
* Affiliation with a social security scheme or beneficiary of such a scheme.
* Native language: French.
* Adolescents who have been informed of the study, have received the study information note and have not objected to participating in the study
* At least one of the holders of parental authority having been informed of the study, having received the relevant information note and not having objected to the adolescent participation
* Consent to audio recording of the SPI-CY scale administration: for the adolescent and at least one parent.

Exclusion Criteria:

* Pregnant woman, parturient or nursing mother
* Person deprived of liberty by judicial or administrative decision
* Person in a life-threatening emergency
* Impairment of the subject that makes it difficult, if not impossible, to participate in the trial or to understand the information provided.
* Abuse or dependence on any substance according to DSM V criteria, excluding cannabis

Where it's running

• Centre Psychothérapique de Nancy
  Nancy, France Recruiting
• CH Alpes-Isère
  Saint-Egrève, France Recruiting
• CHRU Lille
  Lille, France Not yet recruiting

Study contacts

• Principal investigator: Florent BERNARDIN — Centre Psychothérapique de Nancy (CPN)
• Study coordinator: Florent BERNARDIN
• Email: florent.bernardin@cpn-laxou.com
• Phone: 0033 3 83 26 08 63

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Accelerated Brain Stimulation for Young People at Risk of Psychosis

  This study tests a five-day accelerated brain-stimulation treatment to see if it is safe and tolerable for young people at risk for psychosis and to explore biomarkers that might show whether it works.

  Recruiting Douglas Mental Health University Institute · Verdun, Quebec · NCT07786714

• Recovery-oriented suicide prevention for young people at clinical high risk for psychosis

  This program tests a peer-supported, clinician-led suicide prevention group for young people at clinical high risk for psychosis to see if it helps reduce suicidal thoughts and support recovery.

  Recruiting at 2 sites University of California, San Diego · Los Angeles, California and 1 other locations · NCT07756567

• Mindfulness group experiences for young people at high risk for or early in psychosis

  This project tries to understand how group mindfulness sessions feel for French-speaking young people aged 15–30 who are at ultra‑high risk for psychosis or have had a first episode.

  Recruiting at 2 sites Centre Psychothérapique de Nancy · Laxou and 1 other locations · NCT07499934

• Biomarker changes after MT1988 dosing in young people at high risk for psychosis

  This will test whether two doses of MT1988 taken twice daily for 8 weeks change biomarker tests in 17–30-year-olds at high risk for psychosis compared with placebo.

  Recruiting at 15 sites Phase 1/2 Monument Therapeutics Limited · Irvine, California and 14 other locations · NCT07226895

• Digital DBT for Youth at Risk of Psychosis

  This study tests a self-guided digital DBT program to help young people aged 14–35 who are at clinical high risk for psychosis, comparing it to usual care over eight weeks.

  Recruiting Centre for Addiction and Mental Health · Toronto, Ontario · NCT06928935

• Cognitive training and enhanced treatment for youth at high risk of psychosis in Tunisia

  This study is testing two different treatment approaches to see if they can help young people at high risk for psychosis improve their daily functioning over 12 weeks.

  Recruiting University of California, Los Angeles · Tunis · NCT06582901

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.